Send a Letter to the Administration to Help Lower Insulin Prices
Earlier this year, the U.S. Department of Health and Human Services (HHS) announced a proposal to lower prescription drug prices and out-of-pocket…
European Commission Has Approved Forxiga for Adults with Type 1 Diabetes
It’s official: The European Commission has approved Forxiga® (dapagliflozin and marketed in the United States as Farxiga®) for adults with…
Mini, AP Patch Given FDA Nod for Fast-Track Review
A closed-loop patch insulin pump/CGM system has been granted FDA Breakthrough Device Designation by the FDA. The designation is designed…
Eric Tozer World Marathon Challenge Recap
7 Marathons? Check. 7 Continents? Check 7 Consecutive Days? Check We checked in with Eric Tozer to ask him about…
The 20th Anniversary of the Edmonton Protocol
This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999,…
Insulin Discovered Nearly 100 Years Ago: How Far We’ve Come and the Road Ahead
Incredible strides have been made since the discovery of insulin almost 100 years ago. Insulin formulations have improved dramatically, blood-sugar…
Advocacy in Action: Breakthrough T1D 2019 Government Day
After nearly 500 meetings with Members of Congress, Breakthrough T1D 2019 Government Day has officially come to a close. Over…
JDRF-Backed Start-Up Company to Accelerate Work Through Pfizer
AnTolRx, Inc., a private biotechnology company, has agreed to license its immune tolerance therapy for type 1 diabetes (T1D) to…
Eli Lilly Announces Lower-Cost Generic Insulin
Eli Lilly and Company announced it will begin selling a generic version of its most commonly prescribed insulin -- Humalog
